Holactiv

Holactiv is a topical medication that contains the non‑steroidal anti‑inflammatory drug diclofenac sodium. It is marketed in the European Union and is widely supplied as a skin‑applied preparation, typically a gel or cream, although the exact dosage form is not specified. The product is intended for local relief of pain and inflammation associated with musculoskeletal conditions, and it belongs to the NSAID pharmacological therapeutic class.

Holactiv is indicated for the topical management of mild to moderate musculoskeletal pain and inflammation. It is commonly employed in conditions where systemic NSAID exposure is not required.

- Relief of localized pain from sprains, strains, and minor sports injuries. - Reduction of inflammation in osteoarthritis affecting superficial joints such as the knee or hand. - Symptomatic treatment of rheumatoid arthritis flare‑ups in joints accessible to topical application. - Adjunctive therapy for postoperative pain following minor dermatologic procedures. - Management of tendinitis or bursitis where the affected area can be directly treated.

Topical diclofenac may cause local or systemic adverse reactions, although many users experience no problems.

Common: - Skin irritation, redness, or itching at the application site. - Dryness or peeling of the treated skin. - Mild burning or stinging sensation shortly after application. - Localized swelling or edema. - Transient erythema that resolves within a few hours. - Mild pruritus without secondary infection. - Temporary tingling sensation at the site of application.

Serious: - Allergic contact dermatitis with blistering or widespread rash. - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic NSAID effects including gastrointestinal ulceration or bleeding (rare with topical use). - Cardiovascular events such as increased blood pressure or thrombotic risk (very uncommon). - Severe photosensitivity with blistering on sun‑exposed areas.

When using Holactiv, certain precautions should be observed to minimize risks and ensure safe application.

- Avoid applying to broken, infected, or irritated skin. - Do not use on large surface areas or exceed the recommended amount without medical advice. - Keep the product away from eyes, mucous membranes, and open wounds. - Wash hands thoroughly after application, unless the hands are the treatment site. - Consult a healthcare professional before use if you have a history of cardiovascular disease, gastrointestinal ulcers, or renal impairment. - Do not cover the treated area with occlusive dressings unless directed by a clinician. - Discontinue use and seek medical advice if signs of severe skin reaction or systemic symptoms develop.

Topical diclofenac can interact with certain systemic medications or substances that affect its absorption or increase the risk of adverse effects.

Avoid: - Concurrent use of other NSAIDs or COX‑2 inhibitors applied systemically, which may increase overall NSAID load. - Use with anticoagulants (e.g., warfarin, direct oral anticoagulants) that could raise bleeding risk.

Use with caution: - Combination with corticosteroids, especially when applied over large areas, may enhance skin thinning. - Concurrent use of antihypertensive agents, as NSAIDs can attenuate their efficacy. - Patients on lithium therapy should monitor serum levels, as NSAIDs may reduce lithium clearance. - Use with other topical agents (e.g., retinoids) only under medical supervision to avoid irritation.